Table 1 Table caption

 Informed consent

X

 Eligibility checks

X

 Randomisation and initiation of treatment

X

 Treatment with OROS-MPH or placebo

X

X

X

X

X

X

X

 DIVA (taken from pre-trial records)

X

 MINI 7.0.1 diagnostic interview

X

 MINI 7.0.1 cross disorder symptom ratings

X

X

 Demographic data

X

 WASI-II (general cognitive ability)

X

 RPAQ

X

 CTQ

X

 Drug and alcohol use (AUDIT-C and NIDA)

X

 ZAN-BPD

X

 CAARS –O

X

X

X

X

X

X

X

 AES

X

X

X

X

X

X

X

 Blood pressure and pulse

X

X

X

X

X

X

X

 WRAADS

X

X

X

 ARI-S

X

X

X

 MEWS

X

X

X

 Demographic data

X

 MVQ

X

X

 BSI

X

X

 CGI

X

X

 Weiss-CD

X

 Weight

X

X

X

 Number of critical Incidents (adjudications)^b

X

X

 MOASP

X

X

 MOASE

O

O

 BRCP

X

X

 BRCE

O

O

 Educational engagement (proportion of education sessions attended)^b

O

O

 Positive and negative IEPs (HMP ISIS only)^b

X

X

 CORE-M

X

X

 Concomitant medications and compliance^a

X

X

X

X

X

X

X

X

 Prescribed dose of trial medication and compliance^a

X

X

X

X

X

X

 Withdrawal status

X

X

X

X

X

X

 Study medication guess

X